课题基金 / 基金详情

项目摘要

项目成果

GREGORY MATHEW PALMER的其他基金

相似基金

相关文献

中文摘要
翻译
放射治疗用于治疗大约50%的癌症患者。为了提高治愈率 为了减少放射治疗的短期和长期副作用,我们有 获得了多项NIH资助,用于研究小动物的辐射生物学。杜克大学是 第一个中心获得用于小动物(X-RAD)的第一代微CT/微辐照器 225Cx),它支持了该国在辐射方面最成功的研究项目之一 治疗、辐射损伤和成像。在目标定位方面的重大技术改进, 自那以后,治疗计划和放射治疗与功能成像结合在一起 这些能力对于我们的辐射研究更好地模拟人类辐射是必不可少的 治疗,因此具有最大的相关性和影响。提高我们的临床实践能力 在辐射生物学方面有意义的研究,我们要求一个共享的仪器,结合在船上 成像能力(微型CT),采用适形小束放射治疗和高级治疗 计划软件能够最大限度地采用相同的治疗计划方法和指标 今天在临床上常用的。这被并入了Xstrahl小动物辐射 研究平台(SARRP)。建议的仪器使用最先进的技术为小型 严格模拟我们的放射治疗计划和治疗条件的动物 病人。我们建议使用这项技术来研究(1)肿瘤控制的机制和(2) 放射治疗造成的正常组织损伤。我们将利用星载成像和定制 准直器安全地提供高精度和精确度的大剂量辐射进行解剖 肿瘤控制的机制。这种方法将使我们能够研究具有临床意义的终点 肿瘤治疗。此外,对小动物进行成像和定位肿瘤靶点的能力 治疗将促进对小动物的分阶段放射治疗计划,这是例行公事 用来治疗诊所里的病人。该仪器还将使我们拥有前所未有的能力 将放射治疗集中在器官的一部分,以创建剂量体积直方图(DVH)进行研究 正常组织损伤的机制,并为癌症治疗的先进方法建模(例如, 保留淋巴结用于免疫治疗研究)。这种方法将避免多器官损伤 放射治疗,从而将促进小鼠辐射所致正常组织损伤的研究 动物。总之,这项技术极大地提高了我们学习基础知识的能力 放射生物学问题使用的技术与我们治疗病人的技术相同。将这一点结合起来 杜克大学在辐射研究方面拥有广泛专业知识的新型仪器将带来新的 并将促进将这些发现转化为改进的癌症治疗。
英文摘要
Radiation therapy is used to treat approximately 50% of all patients with cancer. To improve the cure rate with radiation therapy and to decrease the short- and long-term side effects of radiation, we have received multiple NIH grants to study radiation biology in small animals. Duke University was one of the first centers to obtain a first generation microCT/micro-irradiator for use in small animals (X-RAD 225Cx), which has supported one of the most successful research programs in the country in radiation therapy, radiation injury, and imaging. Major technological improvements in target localization, treatment planning, and radiation delivery in combination with functional imaging have occurred since that time, and these capabilities are essential for our radiation research to better mimic human radiation therapy and therefore have the most relevance and impact. To improve our ability to carry out clinically meaningful research in radiation biology, we request a shared instrument that combines on-board imaging capabilities (micro-CT), with conformal small beam radiation therapy and advanced treatment planning software that is capable of the same treatment planning approaches and metrics most commonly used today in the clinic. This is incorporated into the Xstrahl Small Animal Radiation Research Platform (SARRP). The proposed instrument uses state-of-the-art technology for small animals that rigorously simulates the radiation therapy planning and treatment conditions of our patients. We propose to use this technology to investigate (1) mechanisms of tumor control and (2) normal tissue injury by radiation therapy. We will utilize the on-board imaging and the custom collimators to safely deliver large doses of radiation with high precision and accuracy to dissect mechanisms of tumor control. This approach will allow us to study the clinically meaningful endpoint of tumor cure. Moreover, the ability to image small animals and localize the tumor target before each treatment will facilitate fractionated radiation therapy schedules for small animals, which are routinely used to treat patients in the clinic. The instrument will also allow us to have the unprecedented ability to focus radiation therapy on part of an organ, to create dose volume histograms (DVHs) to study mechanisms of normal tissue injury, and to model advanced approaches for cancer therapy (e.g. sparing lymph nodes for immunotherapy studies). This approach will avoid multi-organ injury by the radiation treatment and will thereby facilitate studies of radiation-induced normal tissue injury in small animals. In summary, this technology offers a dramatic improvement in our ability to study fundamental radiation biology questions using the same technology with which we treat patients. Combining this novel instrument with the extensive expertise in radiation research at Duke will bring about new discoveries and will facilitate their translation into improved cancer therapy.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/cancers14184506
发表时间: 2022-09-17
期刊: Cancers
影响因子: 5.2
作者: []
通讯作者:
Optical Molecular Imaging Core
  • 批准号:
    10323308
  • 项目类别:
  • 资助金额:
    $3.88万
  • 财政年份:
    1997
  • 负责人:
    GREGORY MATHEW PALMER
  • 依托单位:
Optical Molecular Imaging Core
  • 批准号:
    10544825
  • 项目类别:
  • 资助金额:
    $3.88万
  • 财政年份:
    1997
  • 负责人:
    GREGORY MATHEW PALMER
  • 依托单位:
海外基金